Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$4.07 USD
+0.14 (3.56%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.02 -0.05 (-1.23%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Aquestive Therapeutics, Inc. [AQST]
Reports for Purchase
Showing records 381 - 397 ( 397 total )
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Business Update: Strong 2018 Financials and Positive Outlook
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
LIBERVANT Pre-NDA Meeting May Allow Submission by YE
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
SYMPAZAN Launched in U.S.; Promising LIBERVANT Data at AES
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Selloff Overdone; Buying Opportunity Ahead of Several Key Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Q3 Cash Lasts into Q3:20 and Covers Several Potential Key Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Last Clinical Study Completed for LIBERVANT NDA Submission in Q4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Multiple Clinical and Regulatory Catalysts on the Horizon
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Unclassified
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Aquestive Therapeutics, Inc.
Industry: Unclassified
Initiate OP; Cant Swallow Pills? Hate Needles? PharmFilm® Could Be for You
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L